Principal Investigator

Yvette P
Awardee Organization

University Of Pittsburgh At Pittsburgh
United States

Fiscal Year
Activity Code
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

Epigenomics of Neurocognitive Function in Breast Cancer

Neurocognitive changes with breast cancer and its treatment are significant symptoms in the majority of women with this disease. Unfortunately, very little is known about the mechanisms that underlie these neurocognitive changes, which in turn limits the development of effective treatments and prevention strategies. Evidence supports that DNA methylation impacts cognitive function (CF) and brain health (BH), exercise impacts DNA methylation, and exercise impacts CF and BH. Although investigating DNA methylation patterns has potential to uncover novel biological underpinnings to help us understand neurocognitive changes within the context of breast cancer and its treatment, no DNA methylation study has evaluated the interrelationships among CF, BH and exercise within the context of breast cancer and its treatment. The purpose of the proposed study is to examine the dynamic DNA methylome to identify genes and biological pathways that are involved with CF and BH within the context of breast cancer and its treatment. This project capitalizes on data and samples generated through an ongoing project that involves women newly diagnosed with early stage breast cancer who will receive aromatase inhibitor (AI) therapy and randomizes them to an exercise intervention or usual care. Because breast cancer and AI therapy impact CF and BH in a negative manner and exercise impacts CF and BH in a positive manner; this project offers an exemplar, unique opportunity to identify biological mechanisms involved in CF and BH within the context of breast cancer and its treatment. Phenotype data for CF will focus on cognitive domains that deteriorate with AI therapy including attention, working memory, and executive function, and brain health will be measured using neuroimaging including regional gray matter volume, white matter architecture, and functional dynamics of the brain. Cognitive function may be mediated by commonly occurring symptoms therefore this study will include evaluating fatigue, sleep problems, depression, and anxiety for their potential to mediate or moderate the impact of DNA methylation on CF and BH. Whole genome DNA methylation data will be generated for all women at two time points: at enrollment when all women will be pre AI therapy and not yet randomized and post 6 months intervention for those randomized to the exercise intervention and usual care. This allows us to address mechanisms for CF and BH within the context of breast cancer prior to therapy, within the context of AI therapy, and within the context of an exercise intervention. An additional aim of this project will replicate significant findings using data and DNA samples from a project that recruits older healthy individuals, randomizes them to an identical exercise intervention, similarly measures CF and BH phenotypes, and collects biological samples at the same time points. Findings from this project have the potential to inform evidence based, mechanistically driven therapeutic interventions to mitigate the negative consequences of cancer and its treatment.


  • Stillman CM, Esteban-Cornejo I, Brown B, Bender CM, Erickson KI. Effects of Exercise on Brain and Cognition Across Age Groups and Health States. Trends in neurosciences. 2020 Jul;43(7):533-543. Epub 2020 May 11. PMID: 32409017
  • Gujral S, Aizenstein H, Reynolds CF 3rd, Butters MA, Grove G, Karp JF, Erickson KI. Exercise for Depression: A Feasibility Trial Exploring Neural Mechanisms. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2019 Jun;27(6):611-616. Epub 2019 Jan 17. PMID: 30797651
  • Wagner MA, Erickson KI, Bender CM, Conley YP. The Influence of Physical Activity and Epigenomics On Cognitive Function and Brain Health in Breast Cancer. Frontiers in aging neuroscience. 2020 May 8;12:123. doi: 10.3389/fnagi.2020.00123. eCollection 2020. PMID: 32457596
  • Arockiaraj AI, Liu D, Shaffer JR, Koleck TA, Crago EA, Weeks DE, Conley YP. Methylation Data Processing Protocol and Comparison of Blood and Cerebral Spinal Fluid Following Aneurysmal Subarachnoid Hemorrhage. Frontiers in genetics. 2020 Jun 26;11:671. doi: 10.3389/fgene.2020.00671. eCollection 2020. PMID: 32670358